welcome
We are very excited to announce that the next 18th St.Gallen International Breast Cancer Conference 2023 will take place from 15 – 18 March 2023 in Vienna/ Austria.
Experts and literally all major breast cancer cooperative groups and centres worldwide, actively engaged in basic and clinical research as well as in clinical management of patients with breast cancer, will again present the latest data, critically reviewed by leading specialists in the field. The conference closes as usual with an update of the widely acknowledged «St. Gallen International Consensus on the primary treatment of individuals with early breast cancer», which will be published only a few months after the conference.
We all look very much forward to be connected again with each other and to meet in Vienna. We are happy to draw your attention to the timeline right here:
Friday, 16 December 2022
Poster abstract submission deadline
Friday, 16 December 2022
Early registration deadline
Tuesday, 28 February 2023
Regular registration deadline
Wednesday, 1 March 2023
Late registration fee applies
We are looking forward to meet many professionals in person again and will very much enjoy meeting old and new friends. For those professionals who will not be able to travel, we will have the possibility to access a virtual platform, with live streaming of all sessions and entry to a virtual exhibition.
Stay tuned and register below for the newsletter of the St.Gallen International Breast Conference 2023 or join us social media!
Your SGBCC 2023 Organising Team
St.Gallen Oncology Conferences
Rorschacherstrasse 150, 9006 St.Gallen/Switzerland
sgbcc@oncoconferences.ch
www.sg-bcc.org
conference programme
Understanding breast cancer complexity to improve patients outcomes
The 18th St.Gallen International Breast Cancer Conference 2023 will merge the best of the last conferences and is offering an innovative programme with a number of interactive sessions to allow for greater exchange between faculty and audiences.
Take a glance at the new programme to see what awaits you at next year’s conference and make sure to not miss any of the exciting themes!
quick-links
> Wednesday, 15 March 2023
Industry sponsored symposium
Industry sponsored symposium
Industry sponsored symposium
Opening and award ceremony
Short break
Session 1: News in breast cancer care since SGBCC 2021
Chairs: Beat Thürlimann (Switzerland)
- Surgery of patients with early breast cancer: Quo vadis? (Walter Weber, Switzerland)
- Access to evidence based radiation therapy for patients with early breast cancer (Philip Poortmans, Belgium)
- What’s new in systemic treatment of patients with early breast cancer (tbc)
- Translational research priorities for patients with early breast cancer (Fabrice André, France)
- Hot topics in survivorship, patient reported outcomes, and Quality of Life (Ann Partridge, USA)
Coffee break
SGBCC Academy
The St.Gallen-Vienna Breast Cancer Care Educationals for Professionals around the world.
Chair: Emiel Rutgers (Netherlands)
Co-Chair: Sara Brucker (Germany)
Discussants: Meteb Al-Foheidi (KSA), Stefan Aebi (Switzerland), Zefei Jiang (China)
Interactive Session I: How to avoid unnecessary mastectomies and unnecessary reconstructions – a global discussion
Chairs: Monica Morrow (USA), Walter Weber (Switzerland)
Panelists: Meteb Al-Foheidi (KSA), Denisse Bretel (Peru), Jana de Boniface (Sweden), Fatima Cardoso (Portugal), Heba Gamal (Egypt), Eun-Sook Lee (Korea), Monica Morrow (USA), Lori Pierce (USA), Zhiming Shao (China), Tanja Spanic (Slovenia), Masakazu Toi (Japan)
Welcome Apéro at the Austria Center Vienna
> Thursday, 16 March 2023
Industry sponsored symposium
Session 2: Genomics, Transcriptomics, ctDNA for disease monitoring and risk stratification
Chairs: Fabrice André (France), Meredith Regan (USA)
- ctDNA dynamics for early assessment of recurrence risk (Nicholas Turner, UK)
- Molecular imaging in breast cancer (Elisabeth G. E. de Vries, Netherlands)
- Multi-omic machine learning prediction of treatment response (Carlos Caldas, Portugal)
- How to assess clinical utility and clinical validity of biomarkers in clinical trials? (Meredith Regan, USA)
Session 3: Immunology in early breast cancer
Chairs: Sherene Loi (Australia), Aleix Prat (Spain)
- Understanding the anti-cancer immune response: Innate and adaptive responses to breast cancer cells (Sherene Loi, Australia)
- Tumor microenvironment in early breast cancer (Carsten Denkert, Germany)
- Multiplexed analysis and spatial histology to predict response (Marleen Kok, Netherlands)
- The future of breast cancer immunotherapy (PD, PDL, vaccines) (Giuseppe Curigliano, Italy)
Lunch break
Industry sponsored symposium
Special lecture I and panel discussion
Chair: Michael Gnant (Austria)
Panelists: David Cameron (UK), Heba Gamal (Egypt), Chiun-Sheng Huang (Taiwan)
Special lecture I
The future of innovation: Why are we conducting clinical trials in countries that are unlikely to be able to afford innovative drugs? (Sara Tolaney, USA)
Session 4: Hereditary Breast Cancer
Chairs: Lisa Carey (USA), Suzette Delaloge (France)
- Imaging, screening & surveillance for individuals with increased hereditary breast cancer risk (Suzette Delaloge, France)
- Local treatment in patients with high risk hereditary breast cancer (Maria Joao Cardoso, Portugal)
- Management of patients harboring medium penetrance genes (Christian Singer, Austria)
- Adjuvant systemic therapy for patients with germline BRCA1/2 mutations (Andrew Tutt, UK)
Session 5: The future treatment landscape in the adjuvant setting
Chairs: Sibylle Loibl (Germany), Martine Piccart (Belgium)
- Post-neoadjuvant options in triple negative disease: PARPi, capecitabine, checkpoint inhibitors (Javier Cortes, Spain)
- Risk assessment in ER positive disease: Who should receive CDK 4-6 inhibitors? (Angela De Michele, USA)
- What’s next? Antibody drug conjugates for breast cancer therapy (Cristina Saura, Spain)
- Integrating new oral SERDs in the adjuvant treatment (David Cameron, UK)
Coffee break
SGBCC Academy
The St.Gallen-Vienna Breast Cancer Care Educationals for Professionals around the world.
Chair: Fatima Cardoso (Portugal)
Co-Chair: Carlos Barrios (Brazil)
Discussants: tbc
Debate I: Early breast cancer: do we need chemotherapy in low genomic/high clinical risk (ER+/HER2-)?
Chairs: Giuseppe Curigliano (Italy), Miguel Martin (Spain)
Debaters: Lisa Carey (USA), Nadia Harbeck (Germany)
Interactive Session II: Too big, too small? Too low, too high? Adjuvant choices when stage and biology do not align.
Chairs: Harold Burstein (USA), Prudence Francis (Australia)
What to do in discordant scenarios? Small tumors with high biological risk? (Case studies)
Short break
Industry sponsored symposium
> Friday, 17 March 2023
Industry sponsored symposium
Session 6: Tailoring breast surgery and radiotherapy
Chairs: Jana de Boniface (Sweden), Lori Pierce (USA)
- Patient selection, dose and fractionation for external beam radiotherapy in patients with early breast cancer (Charlotte Coles, UK)
- Benefits and risks of immediate breast reconstruction after tumorectomy or mastectomy (Marie-Jeanne Vrancken Peeters, Netherlands)
- Breast surgery after neoadjuvant therapy (Andrea V. Barrio, USA)
- Breast surgery for local recurrence (Isabel Rubio, Spain)
Session 7: Controversies in the treatment of the axilla
Chairs: Philip Poortmans (Belgium), Zhiming Shao (China)
- Should imaging-based staging of the axilla be standard care and what is the best imaging modality? (Jörg Heil, Germany)
- Axillary surgery in the adjuvant setting (Jana de Boniface, Sweden)
- Axillary surgery in the post-neoadjuvant setting (Oreste Gentilini, Italy)
- De-escalation of axillary radiotherapy – the time has come! (Icro Meattini, Italy)
Lunch break
Industry sponsored symposium
Debate II: Axillary dissection versus axillary radiation for residual nodal disease
Chairs: Michal Gnant (Austria), Philip Poortmans (Belgium)
Debaters: Orit Kaidar-Person (Israel), Monica Morrow (USA)
Interactive Session III: Controversies and uncertainties in axillary management
Chairs: Walter Weber (Switzerland), Bahadir Gulluoglu (Turkey)
Panelists: Jana de Boniface (Sweden), Oreste Gentilini (Italy), Orit Kaidar-Person (Israel), Eun-Sook Lee (Korea), Monica Morrow (USA), Philip Poortmans (Belgium), Isabel Rubio (Spain)
Short break
SGBCC Academy
The St.Gallen-Vienna Breast Cancer Care Educationals for Professionals around the world.
Chair: Elzbieta Senkus-Konefka (Poland)
Co-Chair: Miguel Martin (Spain)
Discussants: Chiun-Sheng Huang (Taiwan), Gerd Fastner (Austria), tbc
Session 8: Optimizing treatment in patients with HER2-positive breast cancer
Chairs: Hope S. Rugo (USA), tbc
- Assessing HER2 heterogeneity (Frederique Penault-Llorca, France)
- Current adjuvant and neoadjuvant approaches (Nadia Harbeck, Germany)
- Emerging new treatments in HER2 positive breast cancer (Martine Piccart, Belgium)
- ER positive vs ER negative: tackling diversity in HER2 positive breast cancer (Aleix Prat, Spain)
Session 9: Optimizing treatment in patients with triple negative breast cancer
Chairs: Lisa Carey (USA), Zefei Jiang (China)
- Optimal neoadjuvant and adjuvant therapy for patients with early triple negative breast cancer (Hope S. Rugo, USA)
- Optimal systemic therapy for residual disease in TNBC (tbc)
- Tackling triple negative histological subtypes in early breast cancer (Jorge Reis Filho, USA)
- Can we de-escalate immunotherapy and chemotherapy in TNBC? (Hervè Bonnefoi, France)
Debate III: If you achieve pCR after neoadjuvant, do you need adjuvant therapy?
Chairs: Eric Winer (USA), tbc
Debaters: Sibylle Loibl (Germany), Steven Chia (Canada)
Short break
Industry sponsored symposium
> Saturday, 18 March 2023
Industry sponsored symposium
Session 10: Global Prespective on breast cancer treatment
Chairs: Carlos Barrios (Brazil), Binghe Xu (China)
- Breast cancer treatment and research from a global perspective (Benjamin Anderson, World Health Organization)
- Perspective from Asia (Binghe Xu, China)
- Perspective from Africa (Heba Gamal, Egypt)
- Perspective from Latin America (Denisse Bretel, Peru)
Session 11: Optimizing treatment in patients with HR positive breast cancer
Chairs: Stefan Aebi (Switzerland), tbc
- Post-menopausal: Who needs chemotherapy in the neo (adjuvant) setting? (Steven Johnston, UK)
- Pre-menopausal: Who needs chemotherapy in the (neo)adjuvant setting? (Prudence Francis, Australia)
- Can we omit adjuvant endocrine therapy? (Fatima Cardoso, Portugal)
- Duration of endocrine therapy in early breast cancer (Jens Huober, Switzerland)
Short break
Debate IV: Surgery of the primary for stage IV disease
Chairs: William Gradishar (USA), Bahadir Gulluoglu (Turkey)
Presenting data: William Gradishar (USA)
Debaters: Rajendra Badwe (India), Florian Fitzal (Austria)
Special lecture II
Pushing the boundaries for cure – extending early BC to oligometastatic? (David Cameron, UK)
Lunch break
St.Gallen International Consensus Session I
St.Gallen International Consensus Session on the primary treatment of patients with breast cancer 2023
Seeking consensus on evidence and opinions
Moderator and Scientific Secretary: Harold Burstein (USA), Giuseppe Curigliano (Italy)
Short break
St.Gallen International Consensus Session II
St.Gallen International Consensus Session on the primary treatment of patients with breast cancer 2023
Seeking consensus on evidence and opinions
Moderator and Scientific Secretary: Harold Burstein (USA), Giuseppe Curigliano (Italy)
Farewell
SGBCC academy
The St.Gallen-Vienna Breast Cancer Care Educationals for Professionals around the world
St.Gallen Oncology Conferences is renowned for their initiatives to foster research and education in early breast cancer care and the virtual SGBCC 2021 opened new doors to facilitate this mission.
As such we want to introduce the SGBCC Academy for our 2023 edition, which provides lectures on the most important topics in early breast cancer care, broken down by panellists of the St.Gallen Consensus as distinguished experts in the fields.
These will be available on-demand from 3 weeks before congress start and the congress will also feature daily SGBCC Academy sessions during which virtual and on-site participants will have the opportunity to directly ask follow-up questions on the presentation topics and further discuss the most pressing issues faced in client care by physicians around the world.
Featured topics for the 2023 edition will be:
- Early Detection, Diagnosis of Breast Cancer, quality control and Public Health Aspects (Sara Brucker, Germany)
- Breast Surgery Standards in 2023 (Emiel Rutgers, Netherlands)
- Endocrine therapies in early breast cancer (Stefan Aebi, Switzerland)
- Chemotherapy in early breast cancer – who benefits? (tbc)
- State-of-the-art targeted therapies for early breast cancer (tbc)
- Modern radiotherapy for early breast cancer (Gerd Fastner, Austria)
- Overtreament in early breast cancer-who is at risk? (Elzbieta Senkus-Konefka, Poland)
- New drugs on the horizon for early breast cancer (Miguel Martin, Spain)
- Adequate treatment for early breast cancer in LMIC ? (Carlos Barrios, Brazil)
- The importance of defining standards of care for breast cancer (Fatima Cardoso, Portugal)
- Systemic therapy for the elderly (tbc)
- Immunotherapy for early breast cancer – who benefits? (Meteb Al-Foheidi, KSA)
- Luminal B-like cancers and neoadjuvant systemic therapy – who benefits? (tbc)
- Preop MRI: helpful or dangerous for the breast surgeon? (Chiun-Sheng Huang, Taiwan)
- Gene signatures – who benefits? (tbc)
- CDK4/6 Inhibition in early breast cancer – who benefits? (Zefei Jiang, China)
registration
The 18th St.Gallen International Breast Cancer Conference 2023 will return to the Austria Center Vienna from 15 – 18 March 2023. We already look forward to meet many professionals in person again and will very much enjoy meeting old and new friends. For those professionals who will not be able to travel, we will have the possibility to access a virtual platform, with live streaming of all sessions and entry to a virtual exhibition.
> Register here and secure your early-bird ticket on a reduced starting fee!
Registration fees:
| Early-bird fee until 16 December 2022 | Regular fee from 16 December 2022 | Late fee from 1 March 2023 | |
| Regular participant | EUR 790.00 | EUR 950.00 | EUR 1100.00 |
| Trainee* | EUR 480.00 | EUR 600.00 | EUR 720.00 |
| Allied health care professionals* | EUR 230.00 | EUR 300.00 | EUR 370.00 |
| Undergraduate students* | EUR 230.00 | EUR 300.00 | EUR 370.00 |
| Patient advocates* | EUR 230.00 | EUR 300.00 | EUR 370.00 |
| Emerging economies* | EUR 100.00 | EUR 100.00 | EUR 100.00 |
| Press | free registration | free registration | free registration |
*Registration category definition:
| Trainee | The trainee fee is only applicable for master and PhD students as well as for young physicians in training. A certificate from the supervisor or head of department is required. |
| Allied health care professionals | The allied health professional fee applicable for professionals without a medical degree. A confirmation from the head of department is required. Allied Health Professionals include e.g. nutritionist, dieticians, psychologists, physiotherapists, and nurses |
| Undergraduate students | The undergraduate student fee is only applicable for medical students at university/college level who have not finished any medical degree yet. A certificate confirming the undergraduate student status required. |
| Patient advocates | Breast Cancer patients, individually or representing a patient advocacy group. A confirmation of the patient advocacy group may be requested. |
| Emerging economies | The emerging economies fee applies to individuals from low and lower-middle-income economies according to the World Bank listing (https://datahelpdesk.worldbank.org/knowledgebase/articles/906519) |
The registration fee includes:
- conference documentation
- participation in the conference programme – scientific sessions and sponsored industry symposia
- attendance at the opening ceremony & welcome apéro on 15 March 2023
- admission to the industrial exhibition
- coffee breaks
- public transportation ticket (valid from 15 to 18 March 2023)
- certificate of attendance upon submission of an online feedback questionnaire after the conference
- free virtual access to live stream and on-demand videos of selected scientific sessions (on-demand recordings will be accessible for a limited time after the congress)
> Register now and be part of this unique experience!
Group registration
Group registration is possible if your company/institute invites several participants to SG-BCC 2023 and needs one collective invoice for the registrations.
If you would like to register a group of 10 or more delegates, please click on following link: https://mondial.eventsair.com/bcc2023/groupreg.
In case of any further questions please contact sgbcc@mondial-congress.com.
Official Italian Agency for AIFA Procedure
Any Italian pharmaceutical company supporting or participating in a congress abroad, is subjected to an authorization by AIFA (Italian Drug Agency), according to an Italian Government Decree (Decreto Legislativo 219/06 – art. 124).
The request of authorization must be submitted within 60 days before the starting date of the event.
Mondial Congress & Events advises pharmaceutical companies to contact the Official Agency:
Fargo International
Contact: Benedetta Cambria
Via P.Maroncelli 27 – 50137 Firenze (Italy)
email: b.cambria@alifargoint.it
Tel +39 3203830442
Stay tuned and register below for the newsletter of the St.Gallen International Breast Conference 2023!
abstracts
St.Gallen Oncology Conferences has the mission to distribute the knowledge to improve quality care for individuals with early breast cancer worldwide. Your contribution can be a fundamental part of that claim. Do not hesitate and submit your abstract today!
Your abstract for the 18th St.Gallen International Breast Cancer Conference 2023 can be submitted here:
> abstract submission platform
Make sure to submit your work via our abstract submission platform until 16 December, 2022 the latest.
FAQ:
- Abstract structure:
Goals, Methods, Results, Conclusions / Word/Character count: 2,500 characters / Max. number of tables: 3 - Are there any abstract restrictions?
Need to stand up with scientific rules and methods and to be original, presenting unpublished data.
Poster-Abstract presenters are invited to present in Vienna. - What is the meeting theme?
Understanding breast cancer complexity to improve patient outcomes. See www.sg-bcc.org - When do we receive an abstract notification (decision date)?
This is January 26th 2023. - What is your late-breaker criteria? Do you accept late-breaking abstract submissions?
This is a case by case decision. - Do you accept trials in progress?
Generally yes, but need to describe underlying theory, research question, methods and, if available, preliminary data. - Do you accept encore abstracts? If so, are there any restrictions?
These are considered case by case. - May I submit more than one abstract?
Yes you may - How many delegates are attending your congresses?
Please find the numbers in total (3500) or % of oncologists, clinicians etc. as described in the Sponsorship Brochure www.sg-bcc.org - Do you have regional breakdown of the type of delegates?
Yes, please have a look in the Sponsorship Broschure at the website. - For scientific/medical opportunities do you offer:
Abstracts in Embase: yes
Virtual Meeting: yes, but limited
Abstracts in Web of Science: yes - For commercial opportunities, do you offer:
Affiliated events: yes (e.g. Satellite Symposia, IBCSG Annual Meeting, Best of St.Gallen Meetings)
Meeting app: yes
Symposia: yes
Webcasts: yes
Exhibitor/sponsorship opportunities: yes. Please consult the Sponsorship Broschure at the Website www.sg-bcc.org
Stay tuned and register below for the newsletter of the St.Gallen International Breast Cancer Conference 2023 so you won’t miss the latest news.
chairs
Meet our chairs:
Conference co-chairs
Univ. Prof. Dr. Michael Gnant, Medical University of Vienna / Austria
Prof. Dr. med. Beat Thürlimann, Breast Centre, Kantonsspital St.Gallen / Switzerland
Prof. Dr. Walter Weber, University Hospital Basel / Switzerland
Conference founder and honorary chair
Prof. Dr. med. Hans-Joerg Senn, Foundation St.Gallen Oncology Conferences (SONK), St.Gallen / Switzerland
Scientific Programme-Chairpersons
Harold Burstein, Boston/MA, USA
Giuseppe Curigliano, Milano/Italy
Michael Gnant, Vienna/Austria
Philip Poortmans, Antwerp/Belgium
Meredith Regan, Boston/MA, USA
Hans-Jörg Senn, St.Gallen/Switzerland
Beat Thürlimann, St.Gallen/Switzerland
Walter Weber, Basel/Switzerland
Eric Winer, New Haven/CT, USA
press registrations
We are inviting members of the press to join us for the virtual SGBCC 2023 and offer free press registrations for them to cover the event.
Registration as press member
For press registration please fill out the online registration form and select “press” for registration type. In case there are any questions contact Mondial Congress & Events, sgbcc@mondial-congress.com
Press Office
The Conference Secretariat offers journalists full support throughout the meeting. All registered journalists can arrange interviews with physicians and researchers who present their work during the 18th St.Gallen International Breast Cancer Conference. For support arranging an interview, please contact sgbcc@mondial-congress.com outlining the requested interviewee(s), the scope of the interview and availabilities.
Media policies
- Only registered journalists who provided their press credentials prior to the meeting will gain online access. Press registrations are non-transferable.
- Registration is limited to a maximum of three representatives per media outlet.
- Financial analysts, sales, advertising, marketing and public relations personnel may not register as press.
- It is not permitted to record/screen grab any of the official scientific sessions. The use of the St.Gallen International Breast Cancer Conference logo is only allowed with prior written permission of the SONK. It can be requested from the SONK Secretariat.
Copyright of presentation material
- All materials in written or illustrated form presented in the scientific programme are the intellectual property of the authors and all rights reside with them. Recording without proper authorisation by the holder of rights must be considered a violation of copyrights and will be prevented by the organisers of the conference.
Embargo breaks for media reporters
Breaking of the embargo policy by a reporter will lead to one or more of the following measures:
- Immediate suspension of the reporter’s media conference credentials
- Immediate barring of the reporter and all other members of his/her media outlet from the meeting platform
- No access to the next meetings for representatives of the media outlet
accommodation
Every spring, Vienna is bustling with congress and exhibition attendees and visitors for business and pleasure. Take advantage of the attractive hotel booking fees for the best picks in terms of price, comfort and location.
Please find the list of hotels here: SGBCC 2023 Hotel Overview
Availability, especially in on-site hotels, is limited. Make sure you secure a room as soon as possible. The official travel and housing agent for SGBCC 2023 is Mondial Congress & Events. During the registration process you are able to book a hotel room nearby the conference venue.
If you have any specific queries with regard to your booking, please contact:
Mondial Congress & Events Mondial GmbH & Co. KG
Lea Hofer
T office +43 1 58804-228
T mobile +43 676 845 880 701
l.hofer@mondial-congress.com
Warning – accommodation scam alert!
There are an increasing number of fraudulent websites and agencies that impersonate SGBCC 2023.
We would like to alert all participants to be aware of possible scams and to strongly advise you to only use the official SGBCC 2023 Website https://www.oncoconferences.ch/events/sg-bcc-2023/ as well as the official SGBCC 2023 accommodation agency Mondial Congress & Events.
Any other companies are in no way connected with Mondial Congress & Events and SGBCC 2023 and we therefore cannot vouch for the services they are offering. We strongly advise you not to share any credit card details with them.
Unfortunately, these fraudulent websites cannot be prevented and we sincerely regret any inconvenience. If you have any further questions, please don’t hesitate to contact us.
exhibition & sponsorship opportunities
Next year’s conference will merge the best of the last conferences – the 18th St.Gallen International Breast Cancer Conference is offering an innovative programme with a number of interactive sessions to allow for greater exchange between the faculty and audiences – it will give your company numerous opportunities to reach the community!
On the back of our successful virtual St.Gallen International Breast Cancer Conference 2021, we’ve decided that the 18th edition will increase accessibility and interactivity to further increase the outreach and educational mission of the Foundation SONK. For those professionals who will not be able to travel, we will have the possibility to access a virtual platform, with live streaming of all sessions and entry to a virtual exhibition.
- SGBCC 2023 Sponsorship Opportunities
- Online application for exhibition and sponsorship
- Exhibition Package
- Satellite Symposia
- Other Sponsorship Opportunities
- Contact
1. SGBCC 2023 Sponsorship Opportunities
Find all our exciting exhibition and sponsorship opportunities in the brochure:
> SGBCC 2023 Sponsorship Opportunities
2. Online application for exhibition and sponsorship
To sign up for exhibition and sponsorship, you have to complete the online exhibition and sponsorship application form via the following link:
> Online application for exhibition and sponsorship
By completing the exhibition application form, companies agree to the SGBCC 2023 Sponsorship & Exhibition Terms & Conditions. The booking is legally binding upon submission.
Below you can find a summarized but not exhaustive sponsorship opportunity list from our brochure.
3. Exhibition Package (min. 6 sqm)
Early-bird fee until Tuesday, 6 September 2022: € 550/ m2
Regular fee from Wednesday 7, September 2022: € 600/m2
Space allocation procedure will start in summer 2022 and will be done according to the following guidelines: total sponsorship contribution, booth size, date of application and payment of first deposit.
| Wednesday, 15 March 2023 | 08:30-09:30 | € 90,000 | |
| Wednesday, 15 March 2023 | 10:00-11:00 | € 90,000 | |
| Wednesday, 15 March 2023 | 11:30-12:30 | € 110,000 | sold |
| Thursday, 16 March 2023 | 08:00-08:45 | € 90,000 | sold |
| Thursday, 16 March 2023 | 11:30-12:30 | € 110,000 | sold |
| Thursday, 16 March 2023 | 17:45-18:45 | € 100,000 | sold |
| Friday, 17 March 2023 | 08:00-08:45 | € 90,000 | |
| Friday, 17 March 2023 | 11:30-12:30 | € 110,000 | sold |
| Friday, 17 March 2023 | 17:45-18:45 | € 100,000 | sold |
Complete the Online Exhibition and Sponsorship Application to reserve your preferred time slot. Bookings must be submitted and will only be accepted via the online application. No options can be reserved. More details an information in the SGBCC 2023 industry brochure above.
Included benefits:
- Use of the main auditorium
- Broadcast of the live Satellite Symposia on the Virtual Platform
- Publication of symposium programme
- One push notification
- One mailing sent to all registered participants
- 10% discount on the exhibition space
- 5 Full conference registrations
More details and information can be found in the SGBCC 2023 industry brochure above.
5. Many other sponsorship opportunities
- e-poster area
- Water dispensers
- Sitting cubes
- Digital advert on the virtual conference platform
- Video advertising spot
- Mailing to participants
- Article in the SG-BCC newsletters
More details and information can be found in the SGBCC 2023 industry brochure above.
If you have any questions please get in contact with:
Ellen Valckenaere
Senior Industry Relations Manager
Mondial Congress & Events
valckenaere@mondial-congress.com
contact
St. Gallen Oncology Conferences (SONK)
Rorschacherstrasse 150
9006 St.Gallen / Switzerland
+41 71 243 09 90
sgbcc@oncoconferences.ch
newsletter
Stay tuned and register now for the newsletter of the St.Gallen International Breast Conference 2023 or join us on social media!
webcasts
Click on the links below to view the webcasts of the St.Gallen International Breast Cancer Conferences of the previous years: